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Sortilin Affects Glut4 Levels with Little Effect on 
Trafficking Kinetics 




Glucose Transporter Isoform 4 (Glut4) responds to insulin stimulation and takes up glucose into 
the cells, which, in turn, decreases blood sugar levels. The relevance of Glut4 trafficking pertains 
to Type II Diabetes, which is becoming an epidemic in the U.S. In Type II Diabetes Glut4 does 
not respond to insulin. In order to identify where the malfunction occurs, a scheme of the normal 
process must be developed. Many proteins interact with Glut4 as it cycles from endosomes to the 
plasma membrane or from endosomes to Glut4 storage vesicles (GSVs) to the plasma membrane. 
One of those proteins has been identified as sortilin. Sortilin assembles glucose storage vesicles 
(GSVs) in the cell. However, its effects on the kinetics of Glut4 trafficking have not been 
measured. Small hairpin RNA (shRNA) was used to knock down expression of sortilin in 
adipocytes, and sortilin cDNA was used to express the protein in fibroblasts. Then flow 
cytometry was used to record endocytic and exocytic rate constants (ken and kex) of Glut4, as well 
as the cycling pool size (ymax). It is hypothesized that sortilin participates with the slow cycling 
pool which interacts with the GSVs. However, results showed that sortilin is acting in a separate 














     Type II diabetes mellitus is known to cause many complications in the body such as 
glaucoma, neuropathy, and hypertension1. These complications are due to the build-up of sugar 
in the blood which results from inefficient cellular uptake of glucose. Blood sugar is regulated by 
increased glucose uptake in muscle and adipose tissues. Glucose uptake into these tissues is 
increased by means of increased Glut4 cycling. Glucose uptake into adipocytes is limited by the 
number of glucose transporters present in the cell membrane. Insulin regulates glucose transport 
by altering the steady state distribution of Glut4 from a predominantly intracellular localization 
to the plasma membrane, a process known as Glut4 translocation. Glut4 translocation overall, is 
the cycling of glucose transporters from intracellular compartments called endosomes to the 
plasma membrane. Information about the steps of Glut4 trafficking is limited, but it is known 
that Glut4 cycles, via two different pathways. 
     In basal cells, Glut4 is found in slow cycling glucose storage vesicles (GSVs) and a fast 
cycling pathway2. The slow cycling GSV pool is the pool that is stimulated by insulin. Insulin 
stimulation increases the amount of Glut4 in the fast cycling pool by transferring slow GSVs into 
the fast pool and by increasing the exocytic rate constant (kex), and having no change in the 
endocytic rate constant (ken). This increases Glut4 at the plasma membrane and results in a 
higher uptake of glucose2. Under basal conditions, Glut4 is packaged into GSVs which derive 
from the trans-Golgi network (TGN). 
     Assembly of the GSVs requires a sorting receptor protein called sortilin. The expression of 
sortilin is observed only upon differentiation of 3T3-L1 cells and has the important characteristic 
of recruiting Glut4 into the GSVs3, 4. It is important to consider that seventy-five to eighty 
percent of Glut4 are packaged in the GSVs under basal conditions5. This is a substantial amount 
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of the cell’s transporters, which represents the importance of sortilin. It has been shown that 
knockdown of sortilin in adipocytes decreases both formation of GSVs and insulin-regulated 
glucose uptake6. Fibroblasts that were transfected with Glut4, without sortilin, led to degradation 
of the Glut4 transporter6. However, transfection of Glut4 and sortilin in fibroblasts allowed 
formation of fully functioning GSVs and a responsiveness to insulin by redirection of degrading 
Glut4 to recycling Glut46 (Shi J. et. al, 2005). Although sortilin is required for formation of 
GSVs, the mechanism behind decreased glucose uptake in the knockdown cells has not been 
explained. This may be due to increased endocytosis, decreased exocytosis, or a change in the 
cycling pool size of Glut4, each of which can be broken down into further detail. 
     Examination of ken and kex allows quantitation of cycling Glut4 as well as comparison of 
possibly linked proteins. Using our laboratory’s kinetic assays, we can measure the amount of 
Glut4 in the fast cycling pool, the rate constant of exocytosis, and the rate constant of 
endocytosis. Using mathematical modeling combined with these assays, we can also distinguish 
between multiple steps that make up exocytosis: sorting, sequestration into GSVs, release from 
GSVs, and fusion of endosomal transport vesicles and/or GSVs with the plasma membrane. 












Constructs and Transformation 
All DNA samples were graciously provided by Dr. Konstantin Kandror (4). pLenti-V5 backbone 
DNA constructs spotted on filter paper were extracted by incubation in 500μls of sterile 
nuclease-free water for 30min. at room temperature. pLenti-Sortilin Myc/His DNA constructs 
spotted on filter paper were similarly extracted. pLenti-Sortilin shRNA DNA constructs were 
extracted in TE buffer (10 mM Tris-Cl, pH 7.5. 1 mM EDTA). Quality of the DNA extracts were 
confirmed by 260/280 and 260/230 ratios using Nano-drop spectrophotometry. 10μls DNA was 
used to transform One Shot Stbl3 E. coli cells following the recommended protocol (Invitrogen). 
Plated bacteria were incubated at 30°C. 
 
Midi-prep and Gel Analysis 
Midi-preps were done following standard protocols to purify 250mL DNA from transformed 
Stbl3 cells with pLenti-V5 DNA, 250mL transformed Stbl3 cells with pLenti-Sortilin shRNA, 
and 250mL transformed Stbl3 cells with pLenti-Sortilin Myc/His DNA (Promega). Following 
purification, DNA samples were run on a 1% agarose gel (refer to figure 1). 
 
Viral Infections 
Fibroblasts were infected with lentivirus encoding HA-Glut4/GFP as described in Muretta et al., 
2008 (2). After recovery cells were then infected with lentiviruses expressing shRNA targeting 
sortilin (Sortilin KD), with sortilin Myc/His cDNA (Sortilin MH), or with empty pLenti-V5 





Described in Muretta J. et. al, 2008 (2), following experiments, cells were suspended and filtered 
through a 100μm cell strainer and analyzed by Accuri C6 cytometer. Log intensities of scattered 
light (forward scatter, FSC, and side scatter, SSC, with 488 nm excitation) and fluorescence 
(FL1, 488 nm excitation/533 nm emission; FL2, 488 nm excitation/585 nm emission; FL3, 488 
nm excitation/>670 nm emission; FL4, 640 nm excitation/>675 nm emission) were collected. 
Gating using Accuri CFlow Plus was used to distinguish adipocytes from undifferentiated 
fibroblasts and cellular debris. Examples of gating are shown in figure 2. Adipocytes infected 
with HA-Glut4/GFP were gated separately from uninfected cells. Geometric means of the gated 
populations were determined using FCS Express (De Novo Software). Mean Fluorescence ratios 
(MFRs) were determined by the ratio of background-corrected FL4 (antibody labeling) to 
background corrected FL1 (total HA-Glut4/GFP reporter). 
 
Basal to Insulin Transition Assay 
Differentiated fibroblasts were incubated in 37°C in Low Serum Media (LSM: 0.5% 
FBS/DMEM). At each time point, from 60min to 7min, LSM media was removed and cells were 
insulin stimulated for 40min. in 100nM insulin solution (3μls 1mg/mL insulin and 5mL LSM). 
At time zero, cells were left in LSM media and the plate was set in an ice slurry. Media was 
removed from all wells and cells were incubated for 1hr. with ice cold Alexa647-anti-HA 
antibody on ice as described in Habtemichael and Brewer et. al, 2011 (7). Antibody was removed 
and cells were washed with ice cold 1X PBS buffer three times. Collagenase (5mgs collagenase, 
with 4.5mLs 1X PBS, and 500μls of 20% BSA) was added to the cells for 10min in a 37°C water 
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bath. The plate was set back on ice and 1X PBS was added to the digested cells for a total of 
200μL. Flow cytometry was used to analyze the cells. 
 
 Anti-HA Uptake 
3T3-L1 adipocytes expressing HA-Glut4/GFP were incubated for 1 hour in LSM and then 
insulin stimulated in 100nM insulin solution for 45min. For each time point, from 150min to 
2min, all media was removed and 100nM insulin with 50ug/mL Alexa647-anti-HA solution was 
added. When the 0 time point was reached, cells were put in an ice slurry for 5min. and then 
washed with ice cold 1X PBS three times7. Cells were then collagenase-digested and 1X PBS 
was added to the digested cells for a total of 200μL. Cells were then analyzed using flow 
cytometry. Uptake experiments were repeated using 3T3-L1 fibroblasts. 
 
Transition Experiment 
3T3-L1 adipocytes expressing HA-Glut4/GFP were serum-starved in LSM for 1hr. Cells for 
insulin to basal transitions were incubated in 100nM insulin solution for 1hr., and basal to insulin 
transition cells kept in LSM. At each time point from 75min. to 2min., basal cells were insulin 
stimulated with 100nM insulin solution and insulin cells inhibited with 50nM LY294002 (LYi) 
(EMD Chemicals). After completion of the time course, cells were placed on ice for 5min. and 
surface Glut4 labeled with Alexa647-anti-HA7. Antibody was removed and cells were washed 
with ice cold 1X PBS buffer three times. Collagenase (5mgs collagenase, with 4.5mLs 1X PBS, 
and 500μls of 20% BSA) was added to the cells for 10min in 37°C water bath. The plate was set 
back on ice and 1X PBS was added to the digested cells for a total of 200μL. Cells were then 
analyzed using flow cytometry. Experiments were repeated using fibroblasts. 
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α-2-Macroglobulin Uptake and Surface Labeling 
Fibroblasts were starved in serum-free DMEM for 90min. Insulin to basal cells were incubated 
with 100nM insulin for 30min and basal to insulin cells kept in DMEM. For uptake cells, 
4μg/mL Alexa647 α-2-M (0.610mg/mL stock Alexa647 α-2-M in 1mL basal or insulin DMEM) 
was added to each time point from 90min. to 15min. After completion of the time course, cells 
were incubated on an ice slurry for 10min. For surface labeling of cells, 4μg/mL Alexa647 α-2-
M was added on ice for 90min7. All cells were washed with cold DMEM three times. 
Collagenase was added and cells were incubated for 10min. in 37°C water bath. The plate was 
set back on ice and 1X PBS was added to the digested cells for a total of 200μL. α-2-M uptake 


















Purified pLenti-sortilin myc/his cDNA (MH), pLenti-sortilin shRNA (KD), and pLenti-V5 
backbone (V5) DNA were verified in a 1% agarose gel. 
 
Figure 1: 1% Agarose Gel with DNA Constructs 
Lane 1 contains 10ul of the 1Kb ladder. Lane 2 contains 1ul of pLenti-Sortilin Myc/His cDNA. 
Lane 3 has 5ul of pLenti-Sortilin Myc/His cDNA. Lane 4 contains 1ul of pLenti-Sortilin shRNA. 
Lane 5 has 5ul of pLenti-Sortilin shRNA. Lane 6 contains 1ul of pLenti-V5 backbone, and lane 7 





All duplicate samples matched, with the exception of lane 4 and 5 in which the 1ul of pLenti-










Specific gating templates for each cell type (fibroblast and adipocyte) was set in order to analyze 
uptake and transition experiments via flow cytometry. 
 
Figure 2: Flow Cytometry Gating 
(a) Shows selection of adipocytes from cell debris. (b) Is gating between infected versus non-
infected cells. The left gate, P4, is non-infected adipocyte population. The right gate, P5, is GFP 
infected adipocytes. FL1 is the green fluorescence, GFP, used as a stable intracellular expression. 
(c) Shows the correlation between infected GFP adipocytes that also have the anti-HA tag. FL4 
is the red fluorescent antibody, anti-HA for collection of kinetic data.  
 
a.                                                b.      










(d) Shows selection of fibroblasts from cell debris. (e) Exhibits infected and non-infected 
fibroblasts. The left gate, P2, shows non-infected fibroblasts. The right gate, P3, is a GFP 
infected fibroblast population. FL1 is the green fluorescence, GFP, used as a stable intracellular 
expression. (f) Shows the correlation between infected GFP fibroblasts that also have the anti-
HA tag. FL4 is the red fluorescent antibody, anti-HA, for collection of kinetic data. 
 















Once DNA from transformed Stbl3 cells was confirmed, and gating established, 3T3-L1 
fibroblasts were transfected and used for Transition and Uptake experiments. Experiments were 
averaged and normalized. 
 
Figure 3: Total Glut4 Expression in Fibroblasts 
Viral infection carrying cDNA Myc/His tagged sortilin in 3T3-L1 fibroblasts resulted in a 3-fold 
increase in Glut4 expression. Data from six experiments was normalized. 
 
 
Figure 4: Total Surface Glut4 in Fibroblasts 
Fibroblasts under basal and insulin conditions expressed more surface Glut4 with sortilin. Total 









Figure 5: Surface Glut4/ Total Glut4 
Ratios of surface Glut4 over total Glut4 have a smaller difference than that of the total number of 
cell surface Glut4. Based on 4 experiments, there was a 20% increase of surface Glut4 in 




Figure 6: Fibroblast Glut4 Transition Kinetics  
The exponential increase represents a basal to insulin transition where 100nM insulin was added 
to basal cells over a time course of 75min. 50nM LY294002 (EMD Chemicals) was added to 
insulin stimulated cells for insulin to basal transition. Based on 3 experiments there was a 27% 






Figure 7: Fibroblast α-HA Uptake 
100nM insulin with 50ug/mL Alexa647-anti-HA solution was added to fibroblasts over a time 
course of 150min. Based on 3 experiments, fibroblasts expressing sortilin did not have a 




Figure 8: Fibroblast α-2-M Uptake 
Low density lipoprotein receptor-related protein 1 is a receptor for α-2-Macroglobulin which was 
measured in fibroblasts expressing sortilin. 4μg/mL Alexa647 α-2-M was added to starved 








Figure 9: Fibroblast α-2-M Surface Binding 
4μg/mL Alexa647 α-2-M was added to serum starved cells for 90min. There was no significant 
change in surface LRP-1 and a-2-M when sortilin was expressed in fibroblasts. 
 
 
Figure 10: Adipocyte Total Glut4 Expression 
Data was normalized for adipocytes with a knockdown of sortilin. There was a 33-40% decrease 














Figure 11: Adipocyte Surface Glut4 
Total number of Glut4 on the surface of insulin stimulated, sortilin knockdown adipocytes, 




Figure 12: Adipocyte Surface Glut4/ Total Glut4 
The proportion of surface Glut4 to total expression of Glut4 in knockdown adipocytes when 











Figure 13: Adipocyte Glut4 Transition Kinetics 
Serum starved basal adipocytes were stimulated with 100nM insulin over a time course of 
75min. Insulin stimulated adipocytes were inhibited with 50nM LY294002 (EMD Chemicals) 
and ken was calculated. Based on 4 experiments there was no change in the endocytic rate 




Figure 14: Adipocyte Glut4 Uptake Assay 
100nM insulin with 50ug/mL Alexa647-anti-HA solution was added to each time point. 
Adipocytes with sortilin knockdown did not have a change in kex, but had a decrease in the ymax 
which was a 7% decrease of the cycling pool size of Glut4. Two different exponential fits are 





Figure 15: Adipocyte α-2-M Uptake 
Low density lipoprotein receptor-related protein 1 is a receptor for α-2-Macroglobulin which was 
measured in adipocytes with sortilin knockdown. 4μg/mL Alexa647 α-2-M was added to starved 
adipocytes over a time course of 75min. Results showed that a knock down in sortilin decreased 




Figure 16: Adipocyte α-2-M Surface Binding 
4μg/mL Alexa647 α-2-M was added to serum starved cells for 90min. There was a 40% decrease 








Figure 17: How Insulin Regulates Glut4 Trafficking: Hypothesized Role for Sortilin 
In basal cells there is only 10-20% of Glut4 cycling in the constitutive pathway. A majority of 
Glut4 are sequestered in GSVs which are not released to the plasma membrane until insulin 
stimulated. We concluded that sortilin does not have a significant effect on the kinetics of Glut4 
trafficking. Sortilin affects total expression of Glut4 in the cell by retrieval of transporters from 



























     Based on previous studies, sortilin was found to have an effect on the total expression of 
Glut4 in the cell. Without sortilin there was a decrease in GSVs, decrease in Glut4 expression, 
and a decrease in glucose uptake6. We replicated this data and achieved the same results. 
However, in order to specifically identify how the change in total expression of Glut4 occurs in 
cells, kinetic assay were done to determine ken, kex, and cycling pool size. 
     Uptake and transition experiments were done with both fibroblasts and adipocytes. Because 
fibroblasts do not normally express sortilin, they are infected with the pLenti-MH construct. The 
V5 backbone is used as a control in all experiments with both types of cells. Adipocytes express 
sortilin therefore the sortilin targeted shRNA is used to knock down the protein in experiments 
using differentiated fibroblasts.  
     In uptake experiments rate constants of exocytosis and the amount of Glut4 that is cycling are 
determined. The rate constant of exocytosis (kex) is equal to the amount of fluorescence observed 
(kobs). This is due to the cycling of Glut4 and fluorescent labeling. When the transporter fuses 
with the plasma membrane, its HA-tag is exposed to extracellular space where a fluorescent anti-
HA antibody can bind. The fluorescently labeled Glut4 then cycles back into the cell and as time 
increases more Glut4 is labeled until reaching a plateau. The plateau represents all available 
Glut4 having been labeled. 
     Transition experiments measure the kinetics of reaching one steady state to another. As the 
cells become exposed from basal to insulin stimulated conditions, or insulin stimulated to insulin 
inhibited, the kex and ken of Glut4 change accordingly. However, the basal to insulin data cannot 
be fit to a single exponential curve due to an overshoot of in trafficking kinetics. Therefore, only 
the ken is calculated in transition experiments. 
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     LRP-1 is the receptor for a-2-M which colocalizes with Glut4 in the trafficking pathway. A-2-
M uptake and surface experiments are used to study changes in LRP-1. The a-2-m uptake 
experiments are used to determine the kex of LRP-1, and a-2-m surface labeling is used to 
determine the change in amount of LRP-1 at the surface of the cell. 
     In fibroblasts expressing sortilin, we found that total expression of Glut4 and the number of 
surface Glut4 increased 3 to 5-fold when sortilin was expressed. Of the total increase in Glut4 
expression, 20% was an increase in surface Glut4. The increase of expression and surface Glut4 
may be due to the 27% decrease in ken seen in the transition assay. The slower rate of 
endocytosis allows more Glut4 to be at the plasma membrane, hence increasing the surface 
amount. Expressing sortilin in fibroblasts did not have a statistically significant effect on kex or 
the cycling pool size. 
     In adipocytes with a knockdown of sortilin, there was a 33-40% decrease of total Glut4 
expression as well as the total number of Glut4 at the surface. When analyzed as a proportion of 
surface Glut4 to the total expression of Glut4, there was only a 10% decrease of surface Glut4 
when sortilin was knocked down. This ratio was expected to be higher in order to account for the 
33-40% decrease in expression. In addition, based on the transition data, the ken did not change. 
From the uptake data we found that kex did not change, but there was a 7% decrease in the 
cycling pool size of Glut4 when sortilin was knocked down in adipocytes. 
     Based on these results we conclude that sortilin does not significantly affect the kinetics in 
Glut4 trafficking. However, because it has an effect on total Glut4 expression we can assume 
that sortilin is acting in a separate pathway. We assume that sortilin is retrieving the Glut4 from 
lysosomal degradation and allowing more transporters to participate in trafficking. 
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     With the acquired information about sortilin we can continue our study on this protein and 
continue the characterization of Glut4 trafficking. Experiments will be repeated with a second 
and third viral infection for more accurate results and better standardization. Affected protein 
concentrations will be determined by performing Western blots. Finally, mathematical modeling 
and simulation will be applied to test our model.  
     Sortilin is one of the many proteins participating in Glut4 trafficking. Full characterization of 
the pathway requires diligent analysis of each protein. Once the Glut4 pathway is developed, we 
can find which aspects of the trafficking are compromised which lead to insulin resistance and 
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